Consider the metabolic pathway show below that converts substrate A to B with the enzyme A-ase, B to C with B-ase(I), and so forth. Acetyl A-ase Acetate A-ase Deacetylase A-ase B-ase ABCD Protease Inhibition What is the mechanism of regulation of A-ase? Reversible Covalent modification Isoenzymes What is the mechanism of regulation of A-ase? Isoenzymes C-ase Reversible Covalent modification Proteolytic Activation Feedback Inhibition Positive allostery

Consider the metabolic pathway show below that converts substrate A to B with the enzyme A-ase, B to C with B-ase(I), and so forth. Acetyl A-ase Acetate A-ase Deacetylase A-ase B-ase ABCD Protease Inhibition What is the mechanism of regulation of A-ase? Reversible Covalent modification Isoenzymes What is the mechanism of regulation of A-ase? Isoenzymes C-ase Reversible Covalent modification Proteolytic Activation Feedback Inhibition Positive allostery

Biochemistry

9th Edition

ISBN:9781319114671

Author:Lubert Stryer, Jeremy M. Berg, John L. Tymoczko, Gregory J. Gatto Jr.

Publisher:Lubert Stryer, Jeremy M. Berg, John L. Tymoczko, Gregory J. Gatto Jr.

Chapter1: Biochemistry: An Evolving Science

Section: Chapter Questions

Problem 1P

See similar textbooks

Similar questions

The diagram below shows the substrate binding cleft for a protease, providing the substrate structure, and indicating the residues (using one-letter code) that line the four specificity pockets. 1 M F H₂N K R IZ 2 3 P F S W оо E 4 The protease is known to cleave the amide linkage between W and E residues for substrates containing the WEFD sequence. Using 3-letter code with amino acids linked by a "dash" (ex. GLY-ALA), the N-terminal product is A and the C-terminal product is A
Two therapeutics, methotrexate and fluorouracil, inhibit the formation of dTMP, at different points in the synthesis. One is a suicide inhibitor and one is a competitive inhibitor. a. What therapeutic applications are there for inhibiting the synthesis of dTTP? (ie. What are they treating?) b. Identify the which molecule is the competitive inhibitor and which one is the suicide inhibitor and explain how you know.
i submitted this question twice and i got different answers
In bacteria, isocitrate dehydrogenase is regulated by phosphorylation of a specific Ser residue in the enzyme active site. X-ray structures of the phosphorylated and the nonphosphorylated enzyme show no significant conformational differences. How does phosphorylation regulate isocitrate dehydrogenase activity? O The phosphoryl group sterically hinders the substrate. O The phosphorylation bears a negative charge, which repels the substrate. O The phosphoryl group attracts positively charged Ca2* cations, which block the active site on the enzyme. None of the above.
PLP can catalyze both \alpha, \beta elimination reactions and \beta, \gamma - elimination reactions. Propose a mechanism for the following PLP - catalyzed \beta, \gamma elimination
Which of the following are true when enzymes and substrate interact? kı E + S ● ES- -P k-1 the rate of the formation of ES = k1 [ES] the rate of the formation of the product = k2[ES] k1 [ES] = k-1 [ES] the rate of breakdown of ES to reform the enzyme and substrate = K-1[E][S] the rate of formation of ES = k1[E][S]